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The cellular differentiation pathway originating from
the bone marrow leading to early T lymphocytes
remains poorly understood. The view that T cells
branch off from a lymphoid-restricted pathway has
recently been challenged by a model proposing a
common progenitor for T cell and myeloid lineages.
We generated interleukin-7 receptor a (Il7r) Cre
recombinase knockin mice and traced lymphocyte
development by visualizing the history of Il7r expres-
sion. Il7r fate mapping labeled all T cells but few
myeloid cells. More than 85% of T cell progenitors
were Il7r reporter+ and, hence, had arisen from an
Il7r-expressing pathway. In contrast, the over-
whelming majority of myeloid cells in the thymus
were derived from Il7r reporter cells. Thus,
lymphoid-restricted progenitors are the major route
to T cells, and distinct origins of lymphoid and
myeloid lineages represent a fundamental hallmark
of hematopoiesis.INTRODUCTION
T cell production depends on continuous influx of bone marrow-
derived progenitors into the thymus. Despite the importance of
this pathway for the adaptive immune system, the physiologi-
cally relevant thymus-colonizing pathways remain enigmatic
(Bhandoola et al., 2007; Bhattacharya et al., 2008; Petrie and
Kincade, 2005; Rodewald, 1995; Wu, 2006). The reasons are
manifold: comparison of progenitors from bone marrow, blood,
and thymus for cell-surface phenotypes, gene transcription,
and developmental potential failed to identify corresponding
phenotypes in these sites. Progenitors may rapidly change their
cell-surface phenotypes, depending on the microenvironment
in vivo or the assay conditions in vitro (Krueger et al., 2006),
shedding doubt on precursor-product conclusions drawn on
phenotypic comparison of progenitors from different hematopoi-
etic sites. Experimentally, many stem and progenitor popula-
tions can give rise to T cells. Progenitor T (pro T) cells in the
thymus have been suggested to arise from multipotent (Benz
and Bleul, 2005; Schwarz and Bhandoola, 2004), lymphoid-426 Immunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc.restricted (Kondo et al., 1997; Martin et al., 2003; Scimone
et al., 2006), T cell-committed (Krueger and von Boehmer,
2007; Rodewald et al., 1994), or, most recently, from common
T and myeloid progenitors (Bell and Bhandoola, 2008; Wada
et al., 2008). This comprehensive list, ranging from uncommitted
multipotent to fully committed T cell progenitors, illustrates how
ill-defined relevant pathways to the thymus are. This is partly
because of the low number of cells bound for the thymus. In
vivo tracking approaches (fate mapping) in unmanipulated
mice have, to our knowledge, not been rigorously applied to
address this problem. Hence, most available data were obtained
from adoptive cell transfers and from in vitro differentiation in
stromal cell cultures (Schmitt and Zu´n˜iga-Pflu¨cker, 2002).
In vitro, pro T cells have abundant potential for macrophages,
granulocytes, and dendritic cells (Balciunaite et al., 2005; Bell
and Bhandoola, 2008; Wada et al., 2008). If developmental
options are irreversibly lost with progressive hematopoietic
differentiation, lymphoid-restricted progenitors should not give
rise to myeloid progeny. Based on these and other consider-
ations, lymphoid-committed progenitors have recently been
excluded as relevant thymus-colonizing cells. Instead, it has
been claimed that T cells arise from common T and myeloid
progenitors (Bell and Bhandoola, 2008; Wada et al., 2008). If
true, such a ‘‘myeloid-based’’ model of lymphopoiesis (Chi
et al., 2009; Kawamoto and Katsura, 2009) would have far-
reaching consequences for the entire model of hematopoiesis
by challenging the developmental separation into lymphoid
and myeloid pathways (Graf, 2008).
Interleukin-7 receptor (Il7r) is the most crucial cytokine
receptor driving lymphopoiesis in vivo (Fischer et al., 1997;
Peschon et al., 1994; Puel and Leonard, 2000) and a key molec-
ular marker for lymphoid progenitors in bone marrow (Igarashi
et al., 2002; Kondo et al., 1997; Martin et al., 2003) and for
T cell progenitors in blood (Krueger and von Boehmer, 2007;
Rodewald et al., 1994). In contrast, pro T cells apparently lack
Il7r expression (Allman et al., 2003; Rothenberg et al., 2008).
We reasoned that the ‘‘expression history’’ of the Il7r locus
should provide insight into the lymphoid versus nonlymphoid
nature of hematopoietic pathways from stem cells to pro
T cells and should reveal a lymphoid origin of myeloid cells in
the thymus. To noninvasively trace cells expressing Il7r, we
inserted Cre recombinase into the Il7r locus (Il7rCre). We showed
that the vast majority of pro T cells lacked Il7r mRNA but were
marked by prior Il7r expression, indicating their descent from
an Il7r+ upstream progenitor. In contrast, Il7r-driven fate
Figure 1. Generation of the Il7rCre Allele and Fate Mapping Strategy
(A) The endogenous Il7r locus, the gene targeting vector, the targeted allele
including the Neo cassette (Il7rCre Neo), and the final targeted allele (Il7rCre)
are schematically depicted (size of FRT sites [triangles] not to scale). A mini-
gene, composed of an untranslated exon, a splice donor site (SD), an intron,
and a splice acceptor site (SA), all derived from the rabbit beta globin gene
(Kouskoff et al., 1993), followed by codon-improved Cre (iCre) (Shimshek
et al., 2002) and a rabbit beta globin polyadenylation site, was inserted along
with an FRT-flanked Neo-resistance gene into the first exon of the Il7r gene
(see Supplemental Experimental Procedures). Positions of the DNA probe
and of the Avr II restriction sites used for Southern blotting are indicated.
(B) Southern blot analysis of the targeted ESC clone. The DNA probe, shown
in (A), was hybridized to Avr II-digested genomic DNA from wild-type ESCs
as control (left lane) and from targeted ESCs before (clone 49.3; middle lane)
(Il7rCre Neo) and after (clone 49.3DNeo; right lane) (Il7rCre) in vitro deletion
of Neo. DNA fragments of 10.2, 13.8, and 12.6 kb correspond to wild-type,
Il7rCre Neo, and Il7rCre alleles, respectively.
(C) To visualize the history of Il7r expression, Il7rCre mice were crossed to
Cre-dependent ROSA26-YFP (YFP) or ROSA26-RFP (RFP) (not depicted)
reporter mice as stated in each figure legend. In the absence of Cre expres-
sion, the reporter remains off. Permanent or transient Il7rCre expression deletes
the LoxP-flanked stopper (LoxP sites indicated as red triangles) and results in
continuous expression of the reporter. Kinetics and intensity of fluorescent
reporter expression following Cre induction are shown in Figure S1.
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Origin of T Cells and Myeloid Cells in the Thymusmapping excluded myeloid cell types in thymus and spleen,
which is overall incompatible with a model in which T cells and
myeloid lineages share a common progenitor in vivo.
RESULTS
Lymphoid Specificity of Il7rCre-Driven Fate Mapping
In Vivo
We generated a knockin mouse bearing Cre recombinase (Cre)
in the Il7r locus (Il7rCre) to express Cre under the control of theendogenous Il7r gene (Figures 1A and 1B). Il7rCre activity was
revealed by Cre-dependent ROSA26-yellow fluorescent protein
(Srinivas et al., 2001) or ROSA26-red fluorescent protein (Luche
et al., 2007) reporter mice (termed YFP and RFP, respectively).
The fluorescent reporters visualize Il7rCre-expressing cells and
their descendents independent of continuous or transient Il7rCre
expression (Figure 1C). To estimate the time it takes for Cre to
turn on a fluorescent reporter from the ROSA locus, we trans-
fected a ROSA-RFP targeted ESC line (Luche et al., 2007) with
a plasmid encoding a tightly tamoxifen-inducible modified
estrogen receptor (Mer)-Cre-Mer fusion protein (Zhang et al.,
1996). Transfected ESC cultures were enriched for plasmid
expression by puromycin selection before culture in the pres-
ence or absence of tamoxifen. The onset of RFP expression
was detectable already by day 1 (Figure S1). Although the
percentage of reporter+ cells reached its plateau by day 2, the
fluorescence intensity continued to increase up to day 4 (Zhang
et al., 1996) until two distinct populations, reporter and
reporter+, were visible. This kinetic of reporter induction implies
that, following onset of Cre expression, fluorescent reporters
are beginning to be expressed, which is visible by transitory
levels of reporter expression.
Consistent with the lymphocyte-specific expression pattern
of Il7r (Sudo et al., 1993), frequencies of Il7r reporter+ T cells
(99.6 [mean] ± 0.15% [standard deviation]; n = 7 mice), B cells
(99.8 ± 0.08%; n = 7), and NK cells (96.8 ± 0.15%; n = 7) were
high in Il7rCreYFP spleens (Figures 2A and 2B; lymphoid pheno-
types defined in Figure S2). Labeling frequencies were low in
F4/80+CD11b+ cells (2.9 ± 1.6%; n = 7), which contain macro-
phages, and in Gr1high(hi)CD11b+ neutrophils (2.0 ± 1.4%; n = 7)
(Figure 2A and 2B; myeloid phenotypes defined in Figure S2).
Hence, Il7rCre-driven labeling in the spleen was highly inclusive
and exclusive for lymphoid and myeloid lineages, respectively,
which reflects the fidelity of the Il7rCre locus as a reporter of Il7r
expression.
Onset of Il7rCre Expression in Bone Marrow Stem
and Progenitor Populations
In agreement with the concurrence of Il7r expression and
specification of bone marrow progenitors toward lymphoid
lineages (Igarashi et al., 2002; Kondo et al., 1997; Martin
et al., 2003), Il7r reporter labeling was rare in the hematopoietic
stem cell (HSC)-containing bone marrow population (3.8 ±
1.1%; n = 18) (Figure 2C) (see Figure S2 and Supplemental
Experimental Procedures for stem and progenitor cell pheno-
types and references). Il7rCre-driven labeling was also infre-
quent in common-myeloid progenitors (4.4 ± 2.0%; n = 4),
granulocyte-monocyte progenitors (4.2 ± 1.8%; n = 4) (Fig-
ure 2C), and megakaryocyte-erythrocyte progenitors (4.6 ±
1.9%; n = 4) (data not shown). In lymphoid-primed multipotent
progenitors (LMPPs; Figure S2), labeling frequencies were
slightly elevated (9.9 ± 2.7%; n = 18) compared to HSCs
(Figure 2C). As expected from the LinIl7r+Flk2+Kitlow(lo)
Sca-1lo phenotype of common lymphocyte progenitors
(CLPs) in the bone marrow (Karsunky et al., 2008), the majority
(88.0 ± 6.7%; n = 13) of CLPs were Il7r reporter+ (Figure 2C,
Figure 3A, and Figure S3). Overall, this Il7rCre-driven labeling
pattern was consistent with lymphoid-priming of Il7r reporter+
cells in the bone marrow.Immunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc. 427
Figure 2. Labeling Frequencies of Lymphoid and Myeloid Cells in
the Spleen and of Progenitor Cells in Bone Marrow and Thymus
(A andB) In the spleens of Il7rCreYFPmice andofYFPcontrolmice, YFP labeling
frequencieswere determinedby flowcytometry forCD3+Tcells, CD19+Bcells,
CD49b(DX5)+CD3CD19 NK cells, F4/80+CD11b+CD3CD19 (F4/80+)
myeloid cells containing macrophages, and Gr1hiCD11b+CD3CD19 (Gr1hi)
neutrophils (phenotypes used to define lymphoid and myeloid cells in the
spleen and to define HSC and LMPP in bone marrow are shown in
Figure S2). Histograms from individual mice are shown in (A), and data are
summarized in (B), where each dot represents an individual mouse and the
bar indicates the mean of all mice per cell population.
(C) In the bonemarrow, LinKit+Sca-1+Flk2 hematopoietic stem cell-contain-
ing cells (HSC), LinKit+Sca-1+Flk2+ lymphoid-primed multipotent progenitors
(LMPP), LinKit+Sca-1CD34+CD16lo common-myeloid progenitors (CMP),
LinKit+Sca-1CD34+CD16+ granulocyte-monocyte progenitors (GMP), and
LinIl7r+Flk2+KitloSca-1lo common-lymphoid progenitors (CLP) were analyzed
for frequencies of YFP-expressing cells. In the thymus, LinKit+DN1 pro T cells
and LinCD44+CD25+ DN2 pre T cells were examined. Each dot represents an
individualmouse, and the bar indicates themean of all mice per cell population.
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428 Immunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc.Gating of LMPPs into Il7r reporter, Il7r reporterlo, and Il7r
reporter+ cells revealed that a large fraction (34%) of all
reporter-expressing cells were reporterlo. For CLPs, 20% of all
Il7r reporter-expressing cells were reporterlo (Figure S3). The
presence of substantial fractions of reporterlo cells among
reporter-expressing LMPPs and CLPs suggests that many
reporter+ LMPPs and CLPs have only recently undergone
conversion from reporter cells. This view is supported by the
abundant expression of Il7r mRNA in CLPs (see below).
Il7r Expression History of Pro T Cells
Pro T cells in the thymus are defined by their
LinCD44+CD25Kit+ phenotype (Allman et al., 2003; Godfrey
et al., 1993; Matsuzaki et al., 1993; Porritt et al., 2004). We
identified two subsets within pro T cells, a major Il7r reporter+
and a minor Il7r reporter subset (Figure 3B) that were clearly
separable (Figure 3C). On average, 87.6 ± 5.8% (n = 38) of pro
T cells were Il7r reporter+ (Figure 2C). In contrast to LMPPs
and CLPs, only very few (1.6%) reporter-expressing pro T cells
were reporterlo (Figure S3). At the next stage in T cell differentia-
tion (double-negative (DN) 2), labeling frequencies reached
saturation (99.6 ± 0.3%; n = 22) (Figure 2C). The Il7r reporter
may be expressed in pro T cells as a result of active, current
Il7r transcription or as a result of transient Il7r expression at
preceding developmental stages. Unresponsiveness of pro
T cells to Il7 and undetectable or low Il7r mRNA expression
suggested that pro T cells may lack Il7r expression (Allman
et al., 2003; Rothenberg et al., 2008) that comes on in the thymus
at the CD4CD8 DN2 stage. To measure frequencies of Il7r
mRNA+ cells, we analyzed pro T cells and, for comparison,
CLPs by single-cell RT-PCR (Figure 3D and 3E). As an internal
positive control, all cells were analyzed in the same PCR tube
for expression of beta-actin (Actb), and only Actb+ lanes were
included in the analysis. Among 71 individual Il7r reporter+ pro
T cells, only 10 (experiment 1 = 5/33; experiment 2 = 5/38)
expressed Il7r mRNA (Figure 3E). Because the total pro T cell
population consisted predominantly of Il7r reporter+ cells (Fig-
ure 2C, Figure 3B, and Figure S3), frequencies of Il7r mRNA-ex-
pressing cells were similarly low in total pro T cells (experiment
1 = 4/30; experiment 2 = 4/48) (Figure 3E). In contrast, most
CLP (experiment 1 = 13/16; experiment 2 = 11/12) contained
Il7r mRNA (Figures 3D and 3E). Hence, the vast majority of pro
T cells were Il7r reporter+ but lacked Il7r mRNA. Moreover, the
hallmark of recent reporter onset, i.e., low expression of the
Il7r reporter, was almost undetectable in pro T cells. These
findings strongly suggest that intrathymic conversion of
reporter pro T cells into reporter+ pro T cells, if it exists, must
be rare. In contrast, the data are compatible with the notion
that transient Il7r expression marks the major route from HSCs
to pro T cells.
Separate Origins of T Cells andMyeloid Lineages In Vivo
Lymphocyte specification of pro T cells has recently been
refuted in favor of a revised model in which pro T cells have
common T cell andmyeloid potential (Chi et al., 2009; Kawamoto
and Katsura, 2009). These conclusions were in large parts based
on improved single-cell in vitro assays that revealed an unex-
pectedly abundant potential of pro T cells for macrophages
and neutrophils (Bell and Bhandoola, 2008; Wada et al., 2008).
Figure 3. Il7r mRNA and Il7rCre-Driven Reporter
Expression in Common Lymphoid Progenitors in
the Bone Marrow and in Pro T Cells in the Thymus
(A) CLPs from YFP control and from Il7rCreYFP mice were
gated based on their Il7r+Flk2+ phenotype (Karsunky et al.,
2008) (left panels, red gates) and further analyzed for
expression of Kit versus Sca-1 (middle panels). The
KitloSca-1lo phenotype of gated LinIl7r+Flk2+ cells is
shown as an overlay (red contour plot, middle panels)
against expression of Kit versus Sca-1 on all Lin cells
(gray contour plot, middle panels). Histograms (right
panels) show expression of the Il7rCre-driven reporter
(Il7r reporter) in CLP (LinIl7r+Flk2+KitloSca-1lo).
(B) LinCD44+ thymocytes from Il7rCreYFP mice were
stained for Kit versus CD25 (left panel), and pro T cells
(LinCD44+CD25Kit+) (red gate) were analyzed for Il7r
reporter expression (right panel). In Figure S3, the levels
of Il7r reporter expression were directly compared for
LMPP, CLP, and pro T cells.
(C) Pro T cells, as defined in (B), were separated by cell
sorting into Kit+YFP (Il7r reporter pro T cells; left panel),
and Kit+YFP+ (Il7r reporter+ pro T cells; right panel).
(D) Analysis of Il7r mRNA expression by single-cell
RT-PCR. Il7r reporter+ pro T cells (top panel) and CLP
(bottom panel) were directly sorted at one cell per well
into PCR plates and analyzed for expression of Actb
(upper band of 409 bp) and Il7r (lower band of 304 bp).
(E) Summary of RT-PCR analyses depicting the percent-
ages of Il7r mRNA+ cells per all Actb mRNA+ cells for
the indicated populations. Bars indicate the mean plus
standard error of the mean for two independent experi-
ments in which a total of 78 Il7r reporter-non-fractionated
pro T cells (total pro T cells), 71 Il7r reporter+ pro T cells,
and 28 total CLPs were analyzed.
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Origin of T Cells and Myeloid Cells in the ThymusGiven that the Il7r reporter indelibly marked85% of pro T cells,
large fractions of myeloid cells in the thymus should be reporter+
if they were the progeny of reporter+ pro T cells. To this end, we
compared frequencies of Il7r reporter+ cells among myeloid line-
ages in thymus and spleen. Using the myeloid marker F4/80, we
separated F4/80+CD11b+ cells in thymus and spleen into
scatterlo phagocytosis+ macrophages and scatterhi phag-
ocytosis eosinophils (Figure 4). Neutrophils were recognized
by flow cytometry as Gr1hiCD11b+ cells, and their identity was
verified by morphology (Figure S4). Conventional dendritic cells
(cDCs), further separated into myeloid (mDC) and lymphoid
(lyDC) DCs, and plasmacytoid DCs (pDCs) were phenotypically
defined as shown in Figure S5.
Il7r reporter-labeling frequencies for mDCs and lyDCs, pDCs,
macrophages, eosinophils, and neutrophils in thymus and
spleen from Il7rCreRFPmice are presented in Figure 5. Frequen-Immunity 32, 4cies of reporter-labeled cDCs were low in
thymus (mDCs: 10.3 ± 6.7%, n = 5; lyDCs:
9.5 ± 3.0%, n = 5) and spleen (mDCs: 11.4 ±
2.4%, n = 5; lyDCs: 11.6 ± 2.8%, n = 5). These
data provide definitive evidence for separate
origins of thymic cDCs and the vast majority of
pro T cells, i.e., the Il7r reporter+ subset. PDCs
were almost fully marked both in thymus
(89.3 ± 7.2%, n = 3) and spleen (86.8 ± 3.0%,
n = 3). These high labeling frequencies likelyresult from Il7r expression in mature pDCs (Figure S5) (Guimond
et al., 2009; Shigematsu et al., 2004), which precludes conclu-
sions on lymphoid or nonlymphoid origins of pDCs.
Frequencies of Il7r labeling were also low for thymic macro-
phages, eosinophils (Figures 4 and 5), and neutrophils (Figure S4
and Figure 5). No differences between thymus and spleen were
found for eosinophils (1.8 ± 0.7%, n = 5, in thymus versus 1.2 ±
0.4%, n = 5, in spleen; thymus versus spleen p = 0.14). Increased
percentages of reporter+ cells in thymus compared to spleen
were apparent for macrophages (10.1 ± 6.2%, n = 5, in thymus
versus 3.1 ± 0.9%, n = 5, in spleen; thymus versus spleen
p = 0.038), and for neutrophils (18.0 ± 5.4%, n = 6, in thymus
versus 1.3 ± 0.6%, n = 6, in spleen; thymus versus spleen
p < 0.01). It should be noted, however, that macrophages
(1800 ± 780; n = 6 mice) and neutrophils (13400 ± 13900; n = 6
mice) (Iyoda et al., 2005) are very rare cells in the thymus and26–436, March 26, 2010 ª2010 Elsevier Inc. 429
Figure 4. Il7rReporter Expression inMacrophages
and Eosinophils in Thymus and Spleen
Thymi (A–H) and spleens (I–P) were enzymatically di-
gested (see Supplemental Experimental Procedures),
and LinCD11c/loF4/80+CD11b+ cells were analyzed for
forward versus side scatter (B and J). Low side scatter
and high side scatter populations from RFP, pan-RFP,
and Il7rCreRFP mice were analyzed for RFP (Il7r reporter)
expression (C, D, K, and L). The high side scatter popula-
tions consisted of eosinophils as shown by May-Gru¨n-
wald-Giemsa-staining (E and M). The low side scatter
populations consisted of macrophages as shown by
May-Gru¨nwald-Giemsa-staining (F and N) and by phago-
cytosis assays using 0.7 mm (G and O) or 2 mm (H and P)
beads. The 0.7 mm beads were FITC-labeled, rendering
phagocytosis+ macrophages FITC+ by flow cytometry
(data not shown). Scale bar shown in (E) (10 mm) applies
to (E), (F), (M), and (N). Scale bar shown in (G) (10 mm)
applies to (G), (H), (O), and (P). Il7r reporter expression in
neutrophils in thymus and spleen is shown in Figure S4.
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Origin of T Cells and Myeloid Cells in the Thymusthat total numbers of Il7r reporter+ macrophages (180 per
thymus) and neutrophils (2400 per thymus) were far lower
than the absolute number of Il7r reporter+ pro T cells (8000 cells
per thymus). These numbers and their implications for the sug-
gested precursor-product relationships between pro T cells and
myeloid cells in the thymus will be considered in the discussion.
Il7r Reporter Pro T Cells Lack Myeloid Potential
in the Thymus In Vivo
Myeloid cells in the thymus could be the progeny of the 15%
Il7r reporter pro T cells (Figure 2C and 3B). We analyzed the430 Immunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc.in vivo potential of Il7r reporter and, for
comparison, of Il7r reporter+ pro T cells upon
transfer into host thymi (Figure 6). Under all
tested experimental conditions (irradiated and
nonirradiated host thymi; time points of analysis
11, 17, and 21 days after injection), both Il7r re-
porter (Figure 6A and 6C) and Il7r reporter+
(Figure 6B and 6C) pro T cells robustly gave
rise to large numbers of donor thymocytes
(6.1 ± 3.1 3 106, n = 6, for Il7r reporter pro
T cell donor cells and 1.8 ± 1.3 3 106, n = 4,
for Il7r reporter+ pro T cell donor cells; p =
0.31). In contrast, both Il7r reporter and Il7r
reporter+ pro T cells failed to generate in the
thymus substantial numbers of F4/80+ or
CD11c+ myeloid cells, which were almost
exclusively host-derived (Figure 6D). These
data demonstrate lack of in vivo myeloid poten-
tial also for Il7r reporter pro T cells.
Developmental Promiscuity of CLPs
and Pro T Cells in In Vitro Assays
Earlier work had suggested that pro T cells and
DCs share a common intrathymic progenitor
(Ardavin et al., 1993) and, more recently, that
the majority of pro T cells retain potential for
macrophages and granulocytes (Bell andBhandoola, 2008; Wada et al., 2008). Because these conclu-
sions are at conflict with our in vivo results, we reexamined the
in vitro potential of pro T cells for myeloid and B lineages and
included, for comparison, CLPs. Both, Il7r reporter and Il7r
reporter+ pro T cells lacked detectable B cell potential on OP9
stroma (0/96 [B cell colonies per number of single cells plated]
for Il7r reporter and 0/96 for Il7r reporter+ pro T cells). In
contrast, LMPPs (17/96) and CLPs (19/96) had abundant B cell
potential. To assay in vitro myeloid potential, individual progen-
itors were cultured on a mixed stromal layer composed of OP9
and OP9-Delta-like-4 (OP9-Dll4) cells (Figure S6), which are
Figure 5. Il7r-Driven Fate Mapping Separates the Origins of T
and Myeloid Lineages in Thymus and Spleen
Thymus and spleen of Il7rCreRFP mice were analyzed for frequencies of RFP+
myeloid cells.RFPwas used instead of YFP because beads applied to demon-
strate phagocytosis (Figure 4) were FITC labeled. Populations analyzed were
MHC class IIhiB220CD11chiCD11b+ myeloid DCs (mDC), MHC class
IIhiB220CD11chiCD11b lymphoid DCs (lyDC), MHC class IIloB220loCD11c+
PDCA1+ plasmacytoid DCs (pDC) (all defined in Figure S5), CD11b+CD11c/lo
F4/80+ side-scatterlo phagocytosis+ macrophages, and CD11b+CD11c/lo
F4/80+ side-scatterhi phagocytosis eosinophils (defined in Figure 4), and
CD11b+Gr1hi neutrophils (defined in Figure S4), RFP labeling frequencies of
pro T cells (81.2 ± 5.4%, n = 8) are shown for comparison. Each dot represents
an individual mouse, and the bar indicates the mean of all mice per cell
population.
Immunity
Origin of T Cells and Myeloid Cells in the Thymusconditions reported to support both T cell and myeloid develop-
ment from pro T cells in vitro (Bell and Bhandoola, 2008; Wada
et al., 2008). Despite the fact that, on a stoichiometric basis,
Il7r reporter+ pro T cells cannot be the physiological progenitors
of macrophages and neutrophils in the thymus (Figure 4, Fig-
ure S4, Figure 5; see also Discussion), these pro T cells yielded
mixed macrophage-neutrophil-T cell colonies at high frequen-
cies (Figure 7A). Likewise, Il7r reporter pro T cells, which lack
myeloid potential upon intrathymic transfer (Figure 6), had a
comparable output of macrophage-neutrophil-T cell colonies
(Figure 7A). Of note, even CLPs, which have little, if any, myeloid
potential in vivo (Kondo et al., 1997; Rumfelt et al., 2006), gener-
atedmixedmyeloid-T cell colonies with frequencies and compo-
sition similar to either of the twopro T cell populations (Figure 7A).
All myeloid progeny arising from CLPs in vitro (examples shown
in Figure 7B and 7C) and, by definition, from Il7r reporter+ pro
T cells expressed the Il7r reporter. Moreover, greater than 90%
of Il7r reporter pro T cell-derived myeloid colonies included
Il7r reporter+ macrophages and neutrophils. Hence, the strict
correlation between Il7r expression and lymphoid, but not
myeloid, lineages observed in vivo was lost in vitro.
DISCUSSION
In contrast to cell-surface expression of the Il7r, which is often
only weakly detectable, the Il7rCre allele revealed the onset of
transcription from the Il7r locus. Importantly, the Cre-dependent
reporter also marked all progeny of Il7r expressers, regardless of
whether or not Il7r continued to be expressed. The choice of this
locus was based on the fact that lymphoid, but not myeloid, line-
ages depend on Il7r function, implying mandatory expression invirtually all lymphoid, but not myeloid, cells. Almost complete
labeling of T-, B-, and NK cells, but only very rare tagging of
myeloid cells in the spleen underscored the lymphoid specificity
of Il7rCre expression. Because Il7r is expressed very early in the
ontogeny of lymphocytes, Il7rCre expression should label hema-
topoietic pathways from the onset of lymphoid specification on.
Il7rCre-driven fate mapping leads to several key findings. The
first concerns the origin of pro T cells. Although many distinct
progenitor populations from bone marrow or blood can experi-
mentally, e.g., after adoptive transfer, colonize the thymus and
give rise to T cells, there is virtually no information on relevant
pathways from bone marrow to thymus in vivo. A defining hall-
mark for lymphoid, but not uncommitted, progenitors or stem
cells in bone marrow is expression of the Il7r. However, up to
now, it has been impossible to trace the fate of Il7r+ lymphoid
progenitors in a normal mouse in vivo. The precursor-product
relationship between Il7r+ lymphoid progenitors in bone marrow
and pro T cells in the thymus remained, therefore, speculative.
Based on unresponsiveness of pro T cells to Il7 in vitro (Allman
et al., 2003), mRNA analysis (Rothenberg et al., 2008), and
the presence of pro T cells in mice lacking Il7 or Il7r expression
(reviewed in Di Santo and Rodewald, 1998), pro T cells were
considered to lack Il7r expression and to be Il7r-independent.
This phenotypic difference between pro T cells (Il7r) and
lymphoid progenitors in bone marrow (Il7r+) has been used to
argue that T cell development may proceed independently of
Il7r+ lymphoid progenitors (Allman et al., 2003). By measuring
frequencies, we found that Il7r expression was indeed undetect-
able in most (90%) pro T cells. This could mean that pro T cells
arise from Il7r progenitors (Benz and Bleul, 2005; Schwarz and
Bhandoola, 2004). Alternatively, the stream of T cell-generating
progenitors may express the Il7r transiently en route to the
thymus and, in this manner, produce Il7r pro T cells. Our
in vivo data now revealed that the vast majority of pro T cells
are descendents of Il7r+ upstream progenitors.
Where does Il7r expression occur along the route from HSCs
to pro T cells? Following onset of Cre expression, fluorescent
reporters are beginning to be expressed, which is visible by
transitory levels of reporter expression. In contrast to LMPPs
and CLPs, pro T cells showed no sign of such transition and
were instead composed of distinct Il7r reporter and Il7r
reporter+ progenitors, strongly suggesting that reporter expres-
sion of Il7r reporter+ pro T cells results from prethymic and tran-
sient expression of the Il7r. Such lymphoid priming may benefit
from the local availability of Il7 in the bone marrow (Mazzucchelli
et al., 2009). In any case, lack of Il7r expression in most pro
T cells had previously masked their origin from Il7r+ progenitors.
In addition to CLPs, small subsets of HSCs and LMPPs were
labeled in Il7rCre mice, and it may be interesting to determine
their in vivo potential.
Second, we identified a minor fraction (15%) of pro T cells
that lacked a history of Il7r expression, providing experimental
support for the long-suspected heterogeneity of thymus-
colonizing progenitors. The fact that progeny of Il7r reporter
pro T cells remained reporter in single-cell colony assays
demonstrates that this subset of pro T cells truly lacks Il7rCre
expression in vivo. It remains to be determined which progeni-
tors in bone marrow or blood are upstream of Il7r reporter pro
T cells. Although the two pro T cell subsets differ in their Il7rImmunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc. 431
Figure 6. Il7r Reporter and Il7r Reporter+ Pro T
Cells Lack Myeloid Potential in the Thymus
(A and B) Il7r reporter pro T cells (A) or Il7r reporter+ pro
T cells (B), each sorted from Il7rCreYFP (CD45.2) mice,
were intrathymically injected into irradiated (6 Gy) adult
CD45.1 recipients. Seventeen days after cell transfer,
donor (left panel, upper gate) and host (left panel, lower
gate) cells were examined for expression of CD4 and
CD8 (middle panels) and of F4/80 and CD11b (right
panels). Percentages indicate the fractions of cells in
each gate.
(C and D) Summary of adoptive transfer experiments of Il7r
reporter and Il7r reporter+ pro T cell-injected thymi. Open
symbols represent injections into adult irradiated mice (as
in A). These thymi were analyzed on day 17, except in one
experiment that was performed 11 days postinjection.
Shaded symbols represent experiments with nonirradi-
ated newborn thymi (CD45.1) that were injected with Il7r
reporter+ or Il7r reporter pro T cells (CD45.2), trans-
planted under the kidney capsule of CD45.1 recipients,
and analyzed 21 days posttransplantation. Total donor
thymocyte yield from thymi injected with Il7r reporter+ or
Il7r reporter pro T cells are shown in (C). In (D), numbers
of donor myeloid cells are given per 106 donor-derived
thymocytes, and numbers of host myeloid cells are given
per 106 host-derived thymocytes. Each dot represents
an individual analysis, and the bar indicates the mean of
all cell numbers per cell population.
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they both displayed T cell-restricted potential in vivo. In
summary, the thymus is predominantly, but not exclusively,
colonized by progenitors that are tagged by Il7r expression.
The third implication of our fate mapping study regards the
developmental relationship between T cells and myeloid cells
in the thymus. That T cells and myeloid cells share a late
common progenitor had originally been proposed for T cells
and subsets of cDCs (‘‘lymphoid DCs’’). Despite the fact that,
to our knowledge, pro T cells have never been shown to give
rise to any DC type in a normal thymus in nonmanipulated
mice in vivo, themodel that pro T cells and subsets of cDCs arise
from a common progenitor in the thymus has been perpetuated
for more than 15 years (Ardavin et al., 1993; Li et al., 2009;
reviewed in Shortman and Naik, 2007). Il7r-driven fate mapping
included the vast majority of pro T cells, yet labeling frequencies432 Immunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc.were similarly low in thymic and splenic cDCs.
Based on these genetic data, we exclude that
cDCs are generated intrathymically from the
bulk of pro T cells. Formally, we cannot rule
out that the few Il7r reporter pro T cells are
DC progenitors, but our cell transfer experi-
ments into host thymi speak against this possi-
bility. However, pro T cells can be hoaxed into
DC fates under certain experimental conditions,
such as ectopic expression of transcription
factors (Laiosa et al., 2006; Rothenberg, 2007)
or Notch1-deletion in pro T cells (Feyerabend
et al., 2009). Fate mapping clearly argues
against such mode of thymic cDC generation
in vivo, a conclusion that is in keeping with thefact that thymic cDCs can develop in the absence of pro
T cells (reviewed in Di Santo et al., 2000).
Pro T cell populations can generate macrophages in vitro
(Balciunaite et al., 2005), and single-cell assays made it highly
unlikely that these macrophages arise from contaminating
myeloid progenitors rather than from bona fide pro T cells (Bell
and Bhandoola, 2008; Wada et al., 2008). While frequencies of
common T-myeloid colonies varied considerably (between
7% [Wada et al., 2008] and 60% [Bell and Bhandoola,
2008] of plated pro T cells), it is evident from these studies
that, in vitro, the macrophage potential of pro T cells is not
rare. CLPs were not analyzed side by side with pro T cells in
these reports, perhaps owing to the assumption that CLPs and
pro T cells differed in myeloid potential. Here, we have read-
dressed the in vitro potential of pro T cells and, for comparison,
included CLPs. The results show that all tested lymphoid
Figure 7. Not Only Pro T Cells but Also CLPs Yield
Myeloid Progeny In Vitro
(A) Il7r reporter pro T cells, Il7r reporter+ pro T cells, and
CLPs were deposited by single cell sorting into 96 wells
that were preplated with a mix of OP9 and OP9-Dll4
stromal cells (Figure S6) and that contained lymphoid
and myeloid growth factors (see Supplemental Experi-
mental Procedures). After 11 days, Il7r reporter+ pro
T cells, Il7r reporter pro T cells, and CLPs generated
42/96, 46/96, and 36/96 colonies, respectively. All colo-
nies were analyzed by flow cytometry for their lineage
composition. Colonies were classified into T only (T),
macrophages only (M), neutrophilic granulocytes only
(G), or mixed TMG, TM, TG, or MG. The distribution of
colony types among total colonies is depicted. The data
shown are representative for one out of two (Il7r reporter
pro T cells and Il7r reporter+ pro T cells) and for one out of
three (CLP) independent experiments.
(B and C) Flow cytometric characterization of colonies
developing from CLP in stromal cell cocultures. Colonies
derived from single CLP (unfractionated for Il7r reporter
expression) were analyzed by flow cytometry for cells
expressing F4/80, Gr1, Thy-1, for the Il7r reporter, and
for CD25 and CD44 (data not shown). Macrophages (M)
were recognized as F4/80+Gr1 cells. Neutrophilic granu-
locytes (G) were F4/80Gr1+ cells. T lineage cells (T) were
Thy-1+ F4/80Gr1. The latter were CD25+CD44+ or
CD25+CD44 corresponding to DN2 and DN3 stages of
T cell differentiation (data not shown). Colonies shown
were, upper panel from left to right, mixed TMG, pure T
(expressing Thy-1; data not shown), mixed TM, mixed
MG, and pure M. Cells from the TMG colony were gated
into T lineage, macrophages, and neutrophils and
analyzed for Il7r reporter expression (lower panel). All T
and myeloid lineage progeny derived from CLPs in vitro
were Il7r reporter+. Similar results were obtained by anal-
ysis of mixed progeny from Il7r reporter pro T cells and,
by definition, from Il7r reporter+ pro T cells (data not
shown). (C) Cells designated as T, M, and G were sorted
and analyzed on May-Gru¨nwald-Giemsa-stained cyto-
spins for their morphology. Scale bar shown for T
(10 mm) applies to all panels in (C).
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stromal cells in the presence of both lymphoid and myeloid
growth factors, very efficiently gave rise to large colonies that
were predominantly composed of T and myeloid lineages.
Because CLPs had similar potential at comparably high frequen-
cies, the in vitro myeloid potential is no distinguishing feature of
pro T cells as opposed to CLPs (Rumfelt et al., 2006).
Do pro T cells generate macrophages in vivo? Based on cell
numbers and labeling frequencies, we estimate that one thymus
contains 180 Il7r reporter+ macrophages (besides 1620 Il7r
reporter macrophages), as opposed to 8000 reporter+ pro
T cells. Hence, the vast majority of thymic macrophages arise
from nonlymphoid, Il7r reporter myeloid progenitors and not
from pro T cells. Macrophages might also originate from Il7r
reporter pro T cells, but direct transfer of these progenitors
into nonirradiated or irradiated thymi did not yield donor macro-
phages. These results appear at conflict with the report from
Kawamoto and colleagues, who generated macrophages from
pro T cells and DN2 cells in deoxyguanosine-treated lobes
cultured for 6 days in the presence of growth factors, including
granulocyte-macrophage colony stimulating factor (Gm-Csf)prior to grafting into adult recipient mice (Wada et al., 2008).
Based on histological analyses, donor macrophages were found
in 10% of the lobes. It is not obvious what promoted the gener-
ation of macrophages from pro T cells under these conditions.
Evidence for common T-myeloid progenitors has also been
based on the generation of neutrophils from pro T cells in vitro,
on the detection of TCR rearrangements in DNA from thymic
neutrophils, and on the expression of a V(D)J recombination
reporter in almost half of the neutrophils in thymus but not spleen
(Bell and Bhandoola, 2008). The significance of the in vitro poten-
tial of pro T cells for myeloid cells has been considered above.
PCR amplification of few bands that indicate TCR rearrange-
ments falls short of revealing whether or not this is a frequent
or exceptional event in neutrophils. The V(D)J reporter is not
restricted to T and B cell lineages but also marks subsets of
NK cells and myeloid cells (Borghesi et al., 2004). In our hands,
the vast majority of neutrophils from spleen and thymus were
nonmarked by the Il7r reporter. Given that a proportionality
between V(D)J reporter+ pro T cells and V(D)J reporter+ thymic
neutrophils had been reported (Bell and Bhandoola, 2008), we
were surprised to find that the reverse is true for Il7rCre mice.Immunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc. 433
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only 18% of neutrophils. Nevertheless, this was the highest
frequency among all myeloid lineages analyzed in the thymus.
Total numbers of Il7r reporter+ neutrophils were far lower than
absolute numbers of Il7r reporter+ pro T cells. Because several
neutrophils are expected to be generated per one progenitor,
the generation of neutrophils from Il7r reporter+ pro T cells, if it
occurs, must be a rare event. Moreover, one would need to
postulate that pro T cells have common potential for T cells
and, remarkably restricted, neutrophils, but not for eosinophils,
cDCs, or macrophages. Alternatively, the Il7r reporter+ neutro-
phils in the thymus may correspond to a subset of neutrophils
akin to the one reported to express lymphoid markers, including
recombination activating genes (Puellmann et al., 2006), which
may also explain the labeling of a subset of neutrophils by the
V(D)J reporter mentioned above. Finally, labeling of a subset of
neutrophils by the V(D)J reporter or the Il7r reporter indicates
that lymphoid genes can put a mark on some developing neutro-
phils, but it does not prove that pro T cells make neutrophils
in a normal thymus in vivo.
Considering Il7rCre-driven fatemapping and adoptive transfers
of Il7r reporter+ or Il7r reporter pro T cells, pro T cells do not
retain substantial myeloid potential in vivo. Pro T cells can be
diverted into myeloid fates by genetic manipulations in vivo
and under conditions forcing myeloid development in vitro.
However, our data strongly imply that pro T cells are T cell-
committed at the earliest stages in the thymus and possibly
before. It remains to be determined whether myeloid lineages
enter the thymus as mature cells from the circulation or develop
in the thymus from myeloid-committed progenitors of bone
marrow or spleen origins. In any case, the separation of T lineage
cells from myeloid cells in the thymus by genetic marking of the
lymphoid arm illustrates the fundamental dichotomy of lymphoid
and myeloid lineages during normal hematopoiesis.EXPERIMENTAL PROCEDURES
Gene Targeting, Mice, and Cre Induction in ESCs
Codon-improved Cre (iCre) (Shimshek et al., 2002) was inserted into the first
exon of the Il7r locus in embryonic stem cells (ESCs) to express iCre under
the control of the Il7r promotor. The Il7rCre targeting strategy is depicted sche-
matically in Figure 1. Details of the gene targeting are given in Supplemental
Experimental Procedures. The Cre-dependent reporter mice used to reveal
Il7rCre expression were either the ROSA26-yellow fluorescent protein reporter
mouse (Srinivas et al., 2001) or the ROSA26-tandem dimer red fluorescent
protein (tdRFP) reporter mouse (Luche et al., 2007). All animal experiments
were approved by the Regierungspra¨sidium Tu¨bingen. Tamoxifen-inducible
Cre reporter ESCs were generated by targeting the tdRFP Cre reporter (Luche
et al., 2007) to the ROSA26 locus and subsequently transfecting a tamoxifen-
inducible Cre flanked by mutant estrogen receptors. This plasmid was modi-
fied from pAN-MerCreMer (Zhang et al., 1996) (provided by M. Reth) to harbor
the puromycin resistance gene. ESC transfectants of modified pAN-Mer-
CreMer were enriched by puromycin selection, Cre expression was induced
using 800 nM 4-hydroxy-tamoxifen, and RFP expression was analyzed at
the indicated time points by flow cytometry (Figure S1).
Flow Cytometry
Antibodies used are listed in Supplemental Experimental Procedures. Cells
were blocked with mouse IgG (500 mg/ml) and subsequently stained with anti-
bodies in PBS with 5% FCS for 45 min on ice, washed in PBS with 5% FCS,
and sorted or analyzed on FACS Aria or CantoII instruments (BD Bioscience),
respectively. For bonemarrow and thymus analysis, CD4, CD8, CD11b, CD19,434 Immunity 32, 426–436, March 26, 2010 ª2010 Elsevier Inc.Gr1, and Ter119 antibodies were used as lineage markers, and cells lacking
these markers are referred to as Lin. For DC, macrophage, and eosinophil
analysis, lineagemarkers were CD3, CD4, CD8, CD19, and Ter119 antibodies.
Cell Preparations
For dendritic cell analysis, spleen and thymus were digested (see Supple-
mental Experimental Procedures), and dendritic cells were stained as
described (Feyerabend et al., 2009). For analysis of neutrophils, single-cell
suspensions from thymus and spleen (see Supplemental Experimental Proce-
dures) were phenotypically defined as described (Bell and Bhandoola, 2008).
For analysis of macrophages and eosinophils, Lin-depleted cells were
prepared from thymus and spleen as described for DCs. Cells were kept
in culture for 2.5 hr, harvested by trypsinization, and stained for flow cytometry
(see Supplemental Experimental Procedures). Macrophages and eosinophils
were distinguished as described (McGarry and Stewart, 1991; Voehringer
et al., 2007), and the cellular morphology was determined using May-
Gru¨nwald-Giemsa-stained cytospin preparations of sorted cells.
Phagocytosis Assay
To assay phagocytic activity of macrophages, polystyrene microspheres
(0.7 mm FITC-labeled beads or 2 mm unlabeled beads; Bangs Laboratories)
were preincubated in 1% BSA for 30 min and then added to the Lin-depleted
cells (108 beads/106 cells). After incubation for 2.5 hr, the cells were harvested,
centrifuged through a 3 ml layer of FCS at 300 g for 5 min at 25C to remove
free beads, and stained for flow cytometry (data not shown). Cellular
morphology of phagocytosis+ macrophages was determined using May-
Gru¨nwald-Giemsa-stained cytospin preparations.
Single-Cell RT-PCR
Single cells were sorted into 20 ml RTmix in 96-well PCR plates. Oil was added,
and reverse transcription was run for 50min at 42Cand terminated at 70C for
15 min. 20 ml 23 PCR mix was added, and PCR amplification of Il7r and Actb
was done for 1min at 94C; (10 s at 94C, 20 s at 55C, 35 s at 72C)3 30; then,
0.4 ml Taq-Mix (Expand Long Template PCR System, Roche) was added and
the reaction was run for 15 more cycles with final elongation for 5 min at 72C.
PCR products were 304 bp (Il7r) and 409 bp (Actb). Il7r amplification was done
using forward (fwd) (50- TAC TTC AAA GGC TTC TGG AGC GAG-30 ) and
reverse (rev) (50- ACG CCT TTC ACC TCA TGA ATC TGG-30) oligonucleotides,
and Actb amplification was done using forward (50-ACG CAG CTC AGT AAC
AGT CC-30) and reverse (50-CAT CAC TAT TGG CAA CGA GC-30) oligonucle-
otides. The RT mix per reaction contained 1ml 10 mM dNTP, 0.1 ml 500 ng/ml
Oligo(dT) (Promega), 2 ml 103 RT buffer, 4 ml 25 mM MgCl2, 2 ml 1 M DTT,
1 ml 40 U/ml RNaseOUT, 0.1 ml 200 U/ml Superscript II, 0.2 ml 10% Triton X,
and 9.6 ml water (dNTP, RT buffer, MgCl2, DTT, RNaseOUT, and Superscript
II were purchased from Invitrogen). The 23 PCR mix per reaction contained
4 ml 103 buffer (buffer 1, Expand Long Template PCR System, Roche),
3.2 ml 10 mM dNTP, 4 ml 103 loading buffer (Rediload, Invitrogen), 0.4 ml
Taq-Mix (Expand Long Template PCR System, Roche), 0.4 ml 10% Triton X,
0.4 ml water, 2 ml 10 pM fwd Il7r primer, 2 ml 10 pM rev Il7r primer, 2 ml 2.5 pM
fwd Actb primer, and 2 ml 2.5 pM rev Actb primer.
Analysis of Notch Ligand Expression on Stromal Cells
Expression of Dll4 on OP9-Dll4 stromal cells (provided by A. Cumano) was
analyzed by flow cytometry using an anti-Dll4 antibody (Koch et al., 2008)
(provided by U. Koch and F. Radtke). Murine embryonic feeder cells were
used as negative control for the retroviral Gfp marker, and OP9-Dll1 stromal
cells (Schmitt and Zu´n˜iga-Pflu¨cker, 2002) (provided by J.C. Zu´n˜iga-Pflu¨cker
via A. Rolink) were used as negative control for Dll4 expression (Figure S6).
In Vitro Differentiation
For analysis of in vitro T and myeloid potential, single-cell-sorted progenitors
were cocultured with a mix of OP9 and OP9-Dll4 stromal cells (Figure S6) in
IMDM (GIBCO), 10% FCS, 13 Penicillin/Streptomycin (GIBCO), 13 NEAA
(GIBCO), and 2 mM MTG (Sigma) in the presence of 1% Il-3-conditioned
medium, 5 ng/ml Il-7, 50 ng/ml M-Csf, 1 ng/ml Gm-Csf, 10 ng/ml Flk2 ligand,
50 ng/ml Scf (Kit ligand) (all recombinant mouse factors), and 50 ng/ml
recombinant human IL-6. At day 11, cells were harvested and stained for
F4/80, Gr1, Thy-1 (CD90.2), CD44, and CD25. B cell potential was examined
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after 13 days.
Intrathymic Injection and Thymus Transplantation
Intrathymic injections were performed as described (Rodewald et al., 1994) in
sublethally irradiated (6 Gy) B6.SJL recipients (CD45.1). 200 cells were
injected per lobe, and on day 11 or day 17, thymi were analyzed for donor
contribution to T cells and myeloid cells by flow cytometry. In addition,
newborn nonirradiated B6.SJL thymi were injected with 300 cells per lobe
using a micromanipulator and transplanted under the kidney capsule of
B6.SJL recipients. On day 21, the transplanted thymi were recovered and
analyzed for donor contribution to T cells and myeloid cells.
Statistical Analysis
Unless stated otherwise, average data are expressed as mean ± one standard
deviation. p values were calculated using the unpaired t test and p < 0.05 was
considered significant.
SUPPLEMENTAL INFORMATION
The Supplemental Information includes six figures and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.immuni.2010.03.005.
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